LFCR position history
The shares of Lifecore Biomedical (LFCR) that Greenhaven Road Investment Management, L.P. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2023 Q1: 2,068,898 shares, $78M, 4.5% of portfolio, New
- 2023 Q2: 1,902,639 shares, $184M, 9.3% of portfolio, Reduce −8.0%
- 2023 Q3: 4,386,666 shares, $331M, 8.3% of portfolio, Add +130.6%
- 2023 Q4: 4,733,912 shares, $161M, 12.6% of portfolio, Add +7.9%
- 2024 Q1: 2,144,018 shares, $11M, 4.8% of portfolio, Reduce −54.7%
- 2024 Q2: 2,216,124 shares, $11M, 5.3% of portfolio, Add +3.4%
- 2024 Q3: 2,228,784 shares, $11M, 4.7% of portfolio, Add +0.6%
- 2024 Q4: 3,616,146 shares, $27M, 4.3% of portfolio, Add +62.2%
- 2025 Q1: 3,616,146 shares, $25M, 10.4% of portfolio
- 2025 Q2: 3,694,832 shares, $30M, 10.3% of portfolio, Add +2.2%
- 2025 Q3: 7,389,664 shares, $54M, 8.2% of portfolio, Add +100.0%
- 2025 Q4: 3,682,573 shares, $30M, 5.1% of portfolio, Reduce −50.2%
- 2026 Q1: 3,537,573 shares, $13M, 9.1% of portfolio, Reduce −3.9%
- 2026 Q2: 3,190,769 shares, $17M, 10.9% of portfolio, Reduce −9.8%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|